Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Talen Energy Corp V.TLN


Primary Symbol: TLN

Talen Energy Corporation owns and operates power infrastructure in the United States. The Company produces and sells electricity, capacity, and ancillary services in wholesale power markets in the United States, primarily in PJM and WECC, with its generation fleet principally located in the Mid-Atlantic region of the United States and Montana. The majority of its generation is produced at its zero-carbon nuclear and lower-carbon gas-fired facilities. Its generation capacity is 10,665 megawatts (MW). Its segments include PJM and Other. The PJM segment is engaged in electricity generation, marketing activities, commodity risk and fuel management within the PJM RTO or ISO markets and comprises Susquehanna and Talen’s natural gas and coal generation facilities. Its Other segment includes the operating and marketing activities of Talen Montana’s proportionate share of the Colstrip Units in the WECC market, the operating activities of Nautilus, and other development activities.


NDAQ:TLN - Post by User

Bullboard Posts
Comment by Everswanon Jun 01, 2009 1:07pm
126 Views
Post# 16033390

RE: BigP

RE: BigP
I'll give u and example of how pumping is impossible.


Take Shigamabs, the third lead product of TLN
It,s an anti-body that attach itself to the Shiga toxin (excrement of the E. Coli bacteria)
E. Coli itself is harmless to human, it's the toxin generated by it that kills poison.

Well, the tech work because you can see how the toxin is rendered harmless on a molecular level...
FDA basically endorsed it by granting orphan status and accerlated approval. No regulatory risk.
I think there is also a SPA with FDA not sure.
Market is 500 million first year and 55-100 millions recurrent sales, just to replace stock pile.
So even if no E. Coli outbreak, hospital are force to stock and restock Shigamabs.

I can post all day about how it works and how mecanism of rendering this poison is proven.
and how PII/PIII is a formality. It's Just like anti-toxin for snake bites science. It's a proven easy science.
No one is going to jump on Shigabmabs.

Would you?

Yet all the pieces are there to rejoice.
That's the nature of the beast. The biotech beast.

Value is created by private players, ie pharma.
Once they endorse something it's become hot.


I posted about Bi-Parp months ago. I told you how hot that piece of techno was.
Now it's front page ASCO news.
https://www.reuters.com/article/healthNews/idUSTRE5504M520090601?sp=true
Bi-Parp was going broke, bankrupt before Sanofi deal...

As you can see it's a very specialized market. End buyer are Pharma.
The game is to guess what they want.
Not what the stock market think.

How to make money with biotech?

Everyday you build on circumstancial evidence to prove murder.
Then murder happens. You get rich and you sell while the average joe rush in.
I sold Exelexis last week and now it is down... Timing.... I didn't get my 6$ target...

Guessing it right then timing it...



I got an endorser of my theory on TLN... That Nat bank crazy buyer... So far, I am reassured and I am waiting....
That's it.







Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse